Franklin Covey - FC Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Franklin Covey in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FC shares.
View FC analyst ratings or view top-rated stocks.

2 brokerages have issued twelve-month price objectives for Franklin Covey's stock. Their FC share price forecasts range from $60.00 to $60.00. On average, they predict the company's stock price to reach $60.00 in the next twelve months. This suggests a possible upside of 14.6% from the stock's current price.
View analysts price targets for FC or view top-rated stocks among Wall Street analysts.

Franklin Covey's stock was trading at $46.36 at the start of the year. Since then, FC stock has increased by 12.9% and is now trading at $52.34.
View the best growth stocks for 2022 here.

Franklin Covey saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 162,800 shares, a drop of 22.6% from the October 15th total of 210,400 shares. Based on an average daily volume of 64,500 shares, the short-interest ratio is currently 2.5 days. Approximately 1.4% of the shares of the company are sold short.
View Franklin Covey's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, January 5th 2023.
View our FC earnings forecast.

Franklin Covey Co. (NYSE:FC) announced its quarterly earnings data on Thursday, January, 6th. The business services provider reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.24. The business services provider earned $61.26 million during the quarter, compared to analyst estimates of $55.37 million. Franklin Covey had a net margin of 7.01% and a trailing twelve-month return on equity of 18.32%. During the same period in the previous year, the firm posted ($0.06) earnings per share.

66 employees have rated Franklin Covey Chief Executive Officer Bob Whitman on Glassdoor.com. Bob Whitman has an approval rating of 93% among the company's employees. This puts Bob Whitman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Franklin Covey investors own include Enbridge (ENB), Eli Lilly and (LLY), NVIDIA (NVDA), Pfizer (PFE), Royal Bank of Canada (RY), Southern (SO), AbbVie (ABBV), Preferred Apartment Communities (APTS), Alibaba Group (BABA) and Citigroup (C).

Franklin Covey trades on the New York Stock Exchange (NYSE) under the ticker symbol "FC."

Franklin Covey's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (7.60%), Vanguard Group Inc. (4.75%), Pembroke Management LTD (4.41%), Dimensional Fund Advisors LP (3.70%), Rice Hall James & Associates LLC (2.51%) and Blue Grotto Capital LLC (2.08%). Insiders that own company stock include Esther Kay Stepp and Michael Fung.
View institutional ownership trends.

Shares of FC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FC stock can currently be purchased for approximately $52.34.

Franklin Covey (NYSE:FC) has a market capitalization of $727.53 million and generates $262.84 million in revenue each year. The business services provider earns $18.43 million in net income (profit) each year or $1.30 on an earnings per share basis.

The company employs 1,150 workers across the globe.

Franklin Covey's mailing address is 2200 W PARKWAY BLVD, SALT LAKE CITY UT, 84119. The official website for the company is www.franklincovey.com. The business services provider can be reached via phone at (801) 817-1776, via email at investor.relations@franklincovey.com, or via fax at 801-977-1414.